ANI Pharmaceuticals, Inc
Price
FilingsNewest: Form 4, insider tradeNov 18 →InsidersNo open-market buys. 11 insiders sold $13.6M, 35 of 47 sales on a 10b5-1 plan.→Financing →PeersClosest companies: AMPH, HRTX, AMRX→
From the filings
Figures
- Revenue
- $1.04Blast 12 months
- Net income
- $116.8Mlast 12 months
- Operating cash flow
- $189.5Mlast 12 months
- Cash and equivalents
- $420.8Mat the last balance sheet
- Total debt
- $297.7Mat the last balance sheet
- Shares outstanding
- 22.5M shareson issue
Filings, newest first
- Nov 184Insider trade
- Nov 16144Planned insider sale
- Nov 168-KRegulation FD disclosure
- Nov 58-KMaterial agreement
- Nov 510-QQuarterly report
- Nov 58-KResults of operations
- Aug 248-KDirector or officer change
- Aug 710-QQuarterly report
- Aug 78-KResults of operations
- May 218-KDirector or officer change
- Feb 2710-KAnnual report